MAPT and Alzheimer disease: Melatonin, an endogenous hormone that decreases during aging and in AD, has been shown to improve memory loss and learning in 3xTg-AD mice as well as to decrease Aβ accumulation and tau hyperphosphorylation in various AD models [174,175].